Risperidone and parkinson's disease
- 25 January 2002
- journal article
- letter
- Published by Wiley in Movement Disorders
- Vol. 17 (1) , 221-222
- https://doi.org/10.1002/mds.1258
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trialMovement Disorders, 2000
- Clozapine and Risperidone Treatment of Psychosis in Parkinson's DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2000
- Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidoneNeurology, 1999
- Risperidone-Induced Tardive DyskinesiaThe Journal of Clinical Psychiatry, 1998
- The use of risperidone for psychosis and agitation in demented patients with Parkinson's diseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 1997
- Neuroleptic sensitivity to risperidone in Lewy body dementiaThe Lancet, 1995
- The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet studyLife Sciences, 1995
- Risperidone for psychotic and behavioural symptoms in Lewy body dementiaThe Lancet, 1995
- Risperidone in Parkinson's diseaseThe Lancet, 1994
- Risperidone for hallucinations in levodopa-treated Parkinson's disease patientsThe Lancet, 1994